Skip to content
User

David Katz

Matrix Advisors Value Fund

David Katz Amgen Inc stake

total: 54

Matrix Advisors Value Fund AMGN trades

Total transactions:
1
New positions:
1
Held since:
2024 Q4
Held for:
1 quarter
Latest activity:
2024 Q4
According to 2024 Q4 report, David Katz holds 3,800 Amgen Inc (AMGN) shares with a market value of roughly $990.43K accounting for 1.40% of the overall portfolio. To date, the estimated cost basis is nearly $260.64 for "buy" trades. Matrix Advisors Value Fund first purchased AMGN in 2024 Q4, initially acquiring 3,800 shares.

How many AMGN shares does David Katz currently hold?

According to 2024 Q4 report, David Katz holds 3,800 shares of Amgen Inc (AMGN), valued at around $990.43K.

When did David Katz buy Amgen Inc (AMGN)?

David Katz first invested in Amgen Inc (AMGN) in 2024 Q4 at the reported quarter-end price of $260.64 per share.

What's the cost basis of Matrix Advisors Value Fund's AMGN stake?

The estimated cost basis for Amgen Inc (AMGN) stake is around $260.64 per share. This represents their average reported price* across all buy transactions

Estimated cost basis*

Weighted AVG buy price:
$260.64

David Katz's historical trades in Amgen Inc

1 result
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2024 Q4
1.40%
3,800
$260.64
$990,432
new
+1.4%
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.